VRDN
USDViridian Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$22.720
Haut
$23.050
Bas
$22.140
Volume
4.98M
Fondamentaux de l'Entreprise
Capitalisation Boursière
2.1B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
1.03M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
BTIG Reiterates Buy on Viridian Therapeutics, Maintains $61 Price Target
BTIG analyst Julian Harrison reiterates Viridian Therapeutics with a Buy and maintains $61 price target.
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
- BLA for veligrotug successfully submitted to the U.S. Food and Drug Administration (FDA) in late October following recent consultation with the agency - - Veligrotug's Breakthrough Therapy Designation supports
Actions Connexes
AIMAU
Aimfinity Investment Corp. I Unit
QRTEP
Qurate Retail Inc. 8.0% Fixed Rate Cumulative Redeemable Preferred Stock
TNC
Tennant Company
MHI
Pioneer Municipal High Income Fund Inc.
IMNM
Immunome Inc.
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.